| 名称 | ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat |
| 型号 | CBP74105 |
| 报价 |  |
| 特点 | ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat,母细胞：Jurkat，冻存条件：90% FBS+10% DMSO |
产品搜索
相关文章
联系我们
联系人：蒋经理
电话：4008750250
号码：
手机：18066071954
地址：南京市栖霞区纬地路9号
Email： zhangxiangwen@cobioer.com
电话：4008750250
号码：
手机：18066071954
地址：南京市栖霞区纬地路9号
Email： zhangxiangwen@cobioer.com
蓝鲸体育在线直播平台官网
/ PRODUCTS
药靶世界杯买球app最新下载安装
> 肿瘤免疫世界杯买球app最新下载安装
> CBP74105ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat
- 详细内容
| CBP74105 | |
| I. Background | |
Antibody-dependent cell-mediated phagocytosis (ADCP) is one of the important mechanisms of action for antibody drug development. | |
| II. Introduction | |
| Host Cell: | Jurkat |
| Expressed gene: | FcγRIa_NFAT |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | N/A |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin |
| Storage: | Liquid nitrogen. |
| Application(s): | Functional(Report Gene) Assay |
| III. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | Peripheral blood |
| Disease: | Childhood T acute lymphoblastic leukemia |
| Morphology: | Lymphoblast |
| Growth Properties: | Suspension |
| IV.Representative Data | |
| |
Figure 1：Dose response of Rituximab in ADCP Bioassay Effector Cell FcγRIa/NFAT Reporter-Jurkat (C11)，the EC50 was 1.94ng/ml. | |
